Stock screenerAll disclosures →
EDGAR →
SPRY
Conviction 51HealthcareScan · Thu, Jun 25, 2026SPRY$8.02-23.91%
ResistanceSupportVol 14Insider sell2
Vol MA14 2.49M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price8.02
Change-23.91%
Gap-26.47%
Rel volume10.49×
Avg volume2.27M
Avg $ vol20.41M
SMA 209.40
SMA 508.69
SMA 2009.37
Price vs 50-7.73%
Price vs 200-14.38%
MA stackbearish
50/200 cross—
Supertrenddown · 10.42
RSI (14)40
MACD hist-0.06
MACD crossbear · 0d
Stoch %K / %D15 / 62
ADX (14)29
+DI / −DI21 / 34
RSI divergenceBearish
MACD divergence—
ATR %+9.67%
ADR %6.65%
52w high18.35
52w low6.73
From 52w high-56.29%
Above 52w low+19.17%
New 52w highNo
SqueezeOff
Bollinger width24.87%
%B-0.09
Donchian pos14.93%
Donchian high10.87
Donchian low7.52
AVWAP (52w high)10.54
vs AVWAP high-23.89%
AVWAP (52w low)9.23
vs AVWAP low-13.11%
OBV trendDown
Chaikin MF (20)0.10
Today vs 20d10.49×
Avg vol (14d)2.49M
Avg vol (20d)2.27M
Avg $ vol (20d)20.41M
Market cap796.41M
RS 3m (vs SPY)+27.53%
RS 6m (vs SPY)-7.26%
RS line new highYes
Trend template1/8
Technical rank18.2
1 week-18.99%
1 month-1.84%
3 months+1.52%
6 months-29.40%
1 year-52.21%
YTD-30.20%
P/E-4.65
P/B12.99
P/S9.45
P/FCF-4.65
EPS-1.74
Div yield—
ROE-279.41%
ROA-59.57%
Debt/Eq1.57
Current4.94
EV/EBITDA-4.85
Gross margin—
Net margin-203.25%
Rev growth-5.46%
EPS growth-2241.76%
Price target28.33
Target upside253.24%
Analyst ratingBuy
Institutional97.76%
Ent. value868.61M
Revenue22.68M
Net income-60.62M
Gross profit—
Free cash flow-171.21M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out99.3M
Employees159
ListedWed, Nov 9, 2022
Free float36.1M
Float %36.4%
Short interest25.5M
Days to cover14.1d
Short volume36.5%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.61 vs −$0.53
Last surprise-15.1% miss
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank18.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.02
Support7.72
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SPRY
No recent disclosed trades by Congress in SPRY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SPRY · 1 buy · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Fitzpatrick Alexander A Chief Legal Officer · Common Stock · 2026-06-12 | Sell | 3.35K | $34K | 2026-06-12 | 2026-06-12 |
Karas Eric Chief Commercial Officer · Common Stock · 2026-06-12 | Exercise | 25K | $38K | 2026-06-12 | 2026-06-12 |
Karas Eric Chief Commercial Officer · Common Stock · 2026-06-12 | Sell | 25K | $250K | 2026-06-12 | 2026-06-12 |
Karas Eric Chief Commercial Officer · Stock Option (Right to Buy) · 2026-06-12 | Exercise | 25K | — | 2026-06-12 | 2026-06-12 |
SEC filings
EDGAR filings in SPRY · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.